Neamine Lnhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription

Clinical Cancer Research

Volumn 15, Issue 6, 2009, Pages 1981-1988

  Ibaragi, Soichiro ^a   Yoshioka, Norie ^a   Li, Shuping ^a   Hu, Miaofen G ^b   Hirukawa, Saori ^a   Sadow, Peter M ^c   Hu, Guo Fu ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; NEAMINE; NEOMYCIN; PROTEIN KINASE B; RIBOSOME RNA; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; FRAMYCETIN; PANCREATIC RIBONUCLEASE;

ADOLESCENT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN LOCALIZATION; RNA SYNTHESIS; RNA TRANSCRIPTION; TRANSGENIC MOUSE; TUMOR XENOGRAFT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; GENETIC TRANSCRIPTION; GENETICS; HUMAN; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; FRAMYCETIN; HUMANS; MALE; MICE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RIBONUCLEASE, PANCREATIC; RNA, RIBOSOMAL; TRANSCRIPTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 63549143437     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2593     Document Type: Article

References (41)

1. Yoshioka N,Wang L, Kishimoto K,TsujiT, Hu GF. A therapeutic target for prostate cancer based onangiogenin- stimulated angiogenesis and cancer cell proliferation. Proc Natl Acad Sci U S A 2006;103:14519-24.
2. Olson KA, Byers HR, Key ME, Fett JW. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int J Cancer 2002;98:923-9.
3. Olson KA, Byers HR, Key ME, Fett JW. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res 2001;7:3598-605.
4. Majumder PK,Yeh JJ, George DJ, etal. Prostate intra-epithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc Natl Acad Sci U S A 2003;100:7841-6.
5. KatonaTM, Neubauer BL, Iversen PW, Zhang S, Baldridge LA, Cheng L. Elevated expression of angiogenin in prostate cancer and its precursors. Clin Cancer Res 2005;11:8358-63.
6. Moroianu J, Riordan JF. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci U S A 1994;91:1677 -81.
7. Xu ZP,TsujiT, Riordan JF, Hu GF. Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry 2003;42:121-8.
8. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer 2003;3:179-92.
9. Kishimoto K, Liu S,TsujiT, Olson KA, Hu GF. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005;24:445 -56.
10. TsujiT, SunY, Koji K, et al. Angiogenin is translocated to the nucleus of HeLa cells and is involved in rRNA transcription and cell proliferation. Cancer Res 2005; 65:1352-60.
11. Hu G,Xu C,RiordanJF. Human angiogenin israpidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA. J Cell Biochem 2000;76:452-62.
12. Hirukawa S, Olson KA, Tsuji T, Hu GF. Neamine inhibits xenografic human tumor growth and angio- genesis in athymic mice. Clin Cancer Res 2005;11: 8745-52.
13. Kurachi K, Davie EW, Strydom DJ, Riordan JF,Vallee BL. Sequenceof the cDN Aand gene forangiogenin, a human angiogenesis factor. Biochemistry 1985;24: 5494-9.
14. Li R, Riordan JF, Hu G. Nuclear translocation of human angiogenin in cultured human umbilical artery endothelial cells is microtubule and lysosome independent. Biochem Biophys Res Commun 1997;238: 305-12.
15. Shapiro R, Strydom DJ, Olson KA,Vallee BL. Isolation of angiogenin from normal human plasma. Bio-chemistry1987;26:5141-6.
16. Miyake H, Hara I,Yamanaka K, Gohji K, Arakawa S, Kamidono S. Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence. Cancer1999;86:316-24.
17. Shimoyama S, Gansauge F, Gansauge S, Negri G, OoharaT, Beger HG. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res1996;56:2703-6.
18. Hu GF. Neomycin inhibits angiogenin-induced angiogenesis. ProcNatlAcadSciUSA1998;95: 9791-5.
19. GlasbyJS. Encyclopedia of antibiotics. 3rd ed. New York (NY):JohnWiley&sSons;1993.p.363-7.
20. FordJH, Bergy ME, Brooks AA, et al. Further characterization of neomycin B and neomycin C. J Am Chem Soc1955;77:5311-4.
21. Williams PD, Bennett DB, Gleason CR, Hottendorf GH. Correlation between renal membrane binding and nephrotoxicity of aminoglycosides. Antimicrob Agents Chemother1987;31:570-4.
22. Au S, Weiner N, Schacht J. Membrane perturbation by aminoglycosides as a simple screen of their toxicity. Antimicrob Agents Chemother 1986;30: 395-7.
23. Qian J, Lavker RM,Tseng H. Mapping ribosomal RNA transcription activity in the mouse eye. Dev Dyn 2006;235:1984-93.
24. RuschoffJ, Plate K, BittingerA,Thomas C. Nucleolar organizer regions (NORs). Basic concepts and practical application in tumor pathology. Pathol Res Pract 1989;185:878-85.
25. Trere D, Pession A, Derenzini M. The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp Cell Res 1989;184:131-7.
26. Olson KA, French TC,Vallee BL, Fett JW. A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res 1994;54: 4576-9.
27. Olson KA, Fett JW, French TC, Key ME,Vallee BL. Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci U S A1995;92:442-6.
28. Kao RY, Jenkins JL, Olson KA, Key ME, Fett JW, Shapiro R. A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity. Proc Natl Acad Sci U S A2002;99: 10066-71.
29. Weiner HL, Weiner LH, Swain JL. Tissue distribution and developmental expression of the messenger RNA encoding angiogenin. Science 1987;237: 280-2.
30. Hatzi E, Bassaglia Y, Badet J. Internalization and processing of human angiogenin by cultured aortic smooth muscle cells. Biochem Biophys Res Commun 2000;267:719-25.
31. Xu ZP,Tsuji T, Riordan JF, Hu GF. The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem Biophys Res Commun 2002;294:287-92.
32. Waksman SA, Lechevalier HA. Neomycin, a new antibiotic active against streptomycin-resistant bacteria, including tuberculosis organisms. Science 1949; 109:305 -7.
33. Leach BE,Teeters CM. Neamine, an antibacterial degradation product of neomycin. J Am Chem Soc 1951;73:2794 - 7.
34. Wintrobe M,Thorn G, Adams R, et al. In: Harrison's principles of internal medicine. 6th ed. New York: McGraw-Hill; 1971. p. 749.
35. Sun M, Wang G, Paciga JE, et al. AKT1/PKBa ki- nase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 2001; 159:431 -7.
36. Di CristofanoA, PesceB, Cordon-Cardo C, Pandolfi PP. Pten is essential for embryonic development and tumour suppression. Nat Genet1998;19:348-55.
37. Vogt PK. PI 3-kinase, mTOR, protein synthesis and cancer. Trends Mol Med 2001;7:482-4.
38. Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell 2000;100:387-90.
39. Aoki M, Blazek E,Vogt PK. A role of the kinase mTOR in cellular transformation induced by the oncoproteins PI3K and Akt. Proc Natl Acad Sci U S A 2001;98:136-41.
40. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G. Rapamycin suppresses 5' TOP mRNA translation through inhibition of p70s6k. EMBO J1997;16:3693-704.
41. Terada N, Patel HR,TakaseK, Kohno K, Nairn AC, Gelfand EW. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ri- bosomal proteins. Proc Natl Acad Sci U S A 1994; 91:11477-81.